Skip to main content

Peer Review reports

From: First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

Original Submission
6 Dec 2023 Submitted Original manuscript
14 Jan 2024 Reviewed Reviewer Report
15 Jan 2024 Reviewed Reviewer Report
28 Mar 2024 Author responded Author comments - Jean van Rampelbergh
Resubmission - Version 2
28 Mar 2024 Submitted Manuscript version 2
8 Apr 2024 Reviewed Reviewer Report
2 May 2024 Reviewed Reviewer Report
6 Jun 2024 Author responded Author comments - Jean van Rampelbergh
Resubmission - Version 3
6 Jun 2024 Submitted Manuscript version 3
Publishing
11 Jun 2024 Editorially accepted
21 Jun 2024 Article published 10.1186/s12916-024-03476-y

You can find further information about peer review here.

Back to article page